Reports
Sale
Global Direct-To-Consumer Laboratory Testing Market Share: By Sample Type: Blood, Urine, Saliva, Others; By Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, Others; By Distribution Channel: Online Platforms/Websites, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Direct-To-Consumer Laboratory Testing Market Outlook
The global direct-to-consumer laboratory testing market size was valued at USD 12.4 billion in 2023, driven by the rising prevalence of telemedicine and EHR services across the globe. The market is expected to grow at a CAGR of 26.8% during the forecast period of 2024-2032, with the values likely to rise from USD 15.7 billion in 2024 to USD 105 billion by 2032.
Direct-To-Consumer Laboratory Testing: Introduction
Direct to consumer laboratory testing involves providing the customer with a generated lab test, where they get direct results from the test without engaging with a physician. It has gained high popularity owing to their rapid, accurate and convenient results. DTC testing may not be available for all diseases but they can help in monitoring a prevailing health condition or identify an infectious disease like COVID-19.
Global Direct-To-Consumer Laboratory Testing Market Analysis
Direct to customer lab tests have become highly common after the sudden outbreak of COVID-19. People have become more familiar and comfortable to at home lab tests. Apart from COVID-19, pregnancy test kits also hold a significant share of the market.
The direct-to-consumer laboratory testing market value is driven by the rising digital and artificial intelligence integration and EHR (electronic health record) prevalence. Local testing labs like LigoLab has launched their own consumer portal to facilitate prompt and convenient delivery of results. These platforms are HIPAA compliant and integrate other medical system software as well. With a vision to go beyond at-home testing, companies like Everly Health have been developing virtual care services for effective diagnostic testing, treatment, and ongoing condition management.
In July 2023, Quest Diagnostics launched the first direct to consumer blood test that works by detecting abnormal levels of beta amyloid. The test is aimed at adults aged 18 years or older with Alzheimer running in the family history or with mild dementia. If the results turn out to be positive, then the patient is directly contacted by a doctor. Such services are projected to fuel the direct to customer laboratory testing market growth in the upcoming years.
Global Direct-To-Consumer Laboratory Testing Market Segmentation
Market Breakup by Sample Type
- Blood
- Urine
- Saliva
- Others
Market Breakup by Test Type
- Genetic Testing
- Disease Risk Assessment Testing
- CBC
- Diabetes Testing
- TSH Testing
- Others
Market Breakup by Distribution Channel
- Online Platforms/Websites
- Mobile Applications
- Physical Retail Locations
- Telemedicine Services
- Others
Market Breakup by End User
- Hospitals
- Clinics
- Specialty Labs
- Diagnostic Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Direct-To-Consumer Laboratory Testing Market Overview
North America has held a major portion of the direct-to-consumer laboratory testing market share owing to a well organised medical infrastructure. Healthcare professionals have also worked on educating common people with appropriate utilisation of latest technologies. In addition, the increasing innovation due to presence of impactful healthcare companies is a major factor for driving growth. Europe is a key player holding significant part of the market size.
To meet the rising direct-to-consumer laboratory testing market demand, Asia Pacific region has been observing an increase in the at home test kits manufacturing. Being home to a massive percentage of geriatric population, direct-to-consumer laboratory tests come in handy as the older generation cannot physically move all the time. To ensure easy access to test results, the companies have started providing both soft and hard copy of the test results.
Global Direct-To-Consumer Laboratory Testing Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- LabCorp
- Quest Diagnostics
- Everlywell
- LetsGetChecked
- HealthTap
- AncestryDNA
- Veritas Genetics
- MyHeritage
- Color Genomics
- Helix
- Orig3n
- Pathway Genomics
- Thermo Fisher Scientific
- Genome Medical
- HealthCheck
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Sample Type |
|
| Breakup by Test Type |
|
| Breakup by Distribution Channel |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Direct-to-Consumer Laboratory Testing Market Overview
3.1 Global Direct-to-Consumer Laboratory Testing Market Historical Value (2017-2023)
3.2 Global Direct-to-Consumer Laboratory Testing Market Forecast Value (2024-2032)
4 Global Direct-to-Consumer Laboratory Testing Market Landscape
4.1 Global Direct-to-Consumer Laboratory Testing Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Direct-to-Consumer Laboratory Testing Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Global Direct-to-Consumer Laboratory Testing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Direct-to-Consumer Laboratory Testing Market Segmentation
6.1 Global Direct-to-Consumer Laboratory Testing Market by Sample Type
6.1.1 Market Overview
6.1.2 Blood
6.1.3 Urine
6.1.4 Saliva
6.1.5 Others
6.2 Global Direct-to-Consumer Laboratory Testing Market by Test Type
6.2.1 Market Overview
6.2.2 Genetic Testing
6.2.3 Disease Risk Assessment Testing
6.2.4 CBC
6.2.5 Diabetes Testing
6.2.6 TSH Testing
6.2.7 Others
6.3 Global Direct-to-Consumer Laboratory Testing Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Online Platforms/Websites
6.3.3 Mobile Applications
6.3.4 Physical Retail Locations
6.3.5 Telemedicine Services
6.3.6 Others
6.4 Global Direct-to-Consumer Laboratory Testing Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Speciality Labs
6.4.5 Diagnostic Centres
6.4.6 Others
6.5 Global Direct-to-Consumer Laboratory Testing Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Direct-to-Consumer Laboratory Testing Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Direct-to-Consumer Laboratory Testing Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Direct-to-Consumer Laboratory Testing Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Direct-to-Consumer Laboratory Testing Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Direct-to-Consumer Laboratory Testing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 LabCorp
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Quest Diagnostics
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Everlywell
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 LetsGetChecked
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 HealthTap
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 AncestryDNA
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Veritas Genetics
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 MyHeritage
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Color Genomics
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Helix
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Orig3n
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Pathway Genomics
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Thermo Fisher Scientific
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 Genome Medical
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 HealthCheck
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Direct-to-Consumer Laboratory Testing Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 12.4 billion in 2023, driven by the increasing prevalence of EHR and telehealth services across the globe.
The market is anticipated to grow at a CAGR of 26.8% during the forecast period of 2024-2032, likely to reach a market value of USD 105 billion by 2032.
The market demand is driven by the rising convergence of digital and artificial intelligence aided platforms into the diagnostic testing areas, which has facilitated prompt, convenient and rapid results in patients.
The current market trend is about the increasing number of at home testing kits being launched for various diseases, which include acute diseases like Alzheimer. Quest Diagnostics launched the first direct to consumer blood test for detecting Alzheimer in patients in July 2023.
Blood, urine, saliva, and others are common sample types in the market.
Based on test type, the market is divided into genetic testing, disease risk assessment testing, CBC, diabetes testing, and TSH testing, among others.
Major distribution channels include online platforms/websites, mobile applications, physical retail locations, and telemedicine services, among others.
Major end users include hospitals, clinics, speciality labs, and diagnostic centres, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are LabCorp, Quest Diagnostics, Everlywell, LetsGetChecked, HealthTap, AncestryDNA, Veritas Genetics, MyHeritage, Color Genomics, Helix, Orig3n, Pathway Genomics, Thermo Fisher Scientific, Genome Medical and HealthCheck.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER